Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Perspectives on urea cycle disorder management: Results of a clinician survey.

Enns GM, Porter MH, Francis-Sedlak M, Burdett A, Vockley J.

Mol Genet Metab. 2019 Sep - Oct;128(1-2):102-108. doi: 10.1016/j.ymgme.2019.07.009. Epub 2019 Jul 18.

2.

Common medical illnesses that affect anesthesia and their anesthetic management.

Agarwal R, Porter MH, Obeid G.

Oral Maxillofac Surg Clin North Am. 2013 Aug;25(3):407-38, vi. doi: 10.1016/j.coms.2013.03.001. Review.

PMID:
23870148
3.

Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Albu JB, Lu J, Mooradian AD, Krone RJ, Nesto RW, Porter MH, Rana JS, Rogers WJ, Sobel BE, Gottlieb SH; BARI 2D Study Group.

Obesity (Silver Spring). 2010 May;18(5):1046-54. doi: 10.1038/oby.2009.339. Epub 2009 Oct 29.

4.

Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats.

Olson DE, Campbell AG, Porter MH, Freeman KG, Kelso E, Flatt WP, Thulé PM.

Mol Ther. 2008 Jul;16(7):1235-42. doi: 10.1038/mt.2008.97. Epub 2008 May 20.

5.

Urticaria after specific bronchial challenge.

Giavina-Bianchi P, Diniz LC, Agondi RC, Porter MH, Kalil J.

J Allergy Clin Immunol. 2008 Jul;122(1):214-5; author reply 215. doi: 10.1016/j.jaci.2008.04.004. Epub 2008 May 12. No abstract available.

PMID:
18468673
6.

Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapy.

Porter MH, Paveglio SA, Zhang JA, Olson DE, Campbell AG, Thulé PM.

J Investig Med. 2005 May;53(4):201-12. doi: 10.2310/6650.2005.00404.

PMID:
15974246
7.

Sexual dimorphism in the response of adipose mass and cellularity to graded caloric restriction.

Porter MH, Fine JB, Cutchins AG, Bai Y, DiGirolamo M.

Obes Res. 2004 Jan;12(1):131-40.

8.

Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats.

Olson DE, Paveglio SA, Huey PU, Porter MH, Thulé PM.

Hum Gene Ther. 2003 Oct 10;14(15):1401-13.

PMID:
14577921
9.

Oxidative phosphorylation: key to life.

Porter MH, Berdanier CD.

Diabetes Technol Ther. 2002;4(2):253-4. No abstract available.

PMID:
12079626
10.

Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations.

Porter MH, Cutchins A, Fine JB, Bai Y, DiGirolamo M.

J Lab Clin Med. 2002 Mar;139(3):140-6.

PMID:
11944024
11.

Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline.

Porter MH, Hrupka BJ, Altreuther G, Arnold M, Langhans W.

Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2113-20.

12.

Protein selection, food intake, and body composition in response to the amount of dietary protein.

White BD, Porter MH, Martin RJ.

Physiol Behav. 2000 Jun 1-15;69(4-5):383-9.

PMID:
10913775
13.

Effects of age on the feeding response to moderately low dietary protein in rats.

White BD, Porter MH, Martin RJ.

Physiol Behav. 2000 Mar;68(5):673-81.

PMID:
10764897
14.

Lipopolysaccharide-induced anorexia following hepatic portal vein and vena cava administration.

Porter MH, Arnold M, Langhans W.

Physiol Behav. 1998 Jul;64(5):581-4.

PMID:
9817566
15.

Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP.

Porter MH, Hrupka BJ, Langhans W, Schwartz GJ.

Am J Physiol. 1998 Aug;275(2):R384-9. doi: 10.1152/ajpregu.1998.275.2.R384.

PMID:
9688672
16.

TNF-alpha tolerance blocks LPS-induced hypophagia but LPS tolerance fails to prevent TNF-alpha-induced hypophagia.

Porter MH, Arnold M, Langhans W.

Am J Physiol. 1998 Mar;274(3):R741-5. doi: 10.1152/ajpregu.1998.274.3.R741.

PMID:
9530241
17.

Health checks for elderly people.

Dunn SJ, Porter MH.

Br J Gen Pract. 1995 May;45(394):272. No abstract available.

Supplemental Content

Loading ...
Support Center